The Scope of Things
The Scope of Things
Latest Episodes
Episode: 51 - Bridging the Equity Gap in Oncology with Eugene Manley, Jr.
Are medical advancements closing or widening medical disparities? Eugene Manley, Jr., Ph.D., founder and CEO of the STEMM & Cancer Health Equity Foundation, breaks down why equity is still not completely measurable in clinical trials, what ...
Episode: 50 - Ramona Burress and Cassandra O’Neal on Health Equity That Works
Health equity is being reorganized, renamed, or quietly deprioritized. Ramona Burress, co-founder of Onyx Health Collective, and Cassandra O’Neal, founder of Illuminated Arc Consulting, join the Scope of Things podcast for a direct, practical c...
Episode: 49 - Mike Sullivan on AI and Clinical Operations in the Year 2030
What will AI and clinical trials look like in the year 2030? Mike Sullivan, head of IT globally for development operations at Bristol Myers Squibb, joins The Scope of Things to discuss how creating value with AI depends on redesigning how clini...
Episode: 48 - Florence Mowlem on the Challenges and Solutions of Pediatric Rare Disease Trials
How can electronic capture of clinical outcome assessments (eCOA) help with the unique challenges of pediatric rare disease trials? Florence Mowlem, chief scientific officer of uMotif, joins The Scope of Things to offer her expertise on eCOA, s...
Episode: 47 - Joseph Kim on Pragmatic Solutions to Age-Old Problems
Joining this month’s episode of The Scope of Things is Joseph Kim, chief strategy officer of ProofPilot, who talks about his company’s first-ever CORE Symposium, where pharma pros shared practical solutions to age-old trial challenges. Kim prov...
